Hanx Biopharmaceuticals (Wuhan) Co. Ltd.HKEX: 3378

Voluntary announcement entering into strategic cooperation with xtalpi

· Issued by Hanx Biopharmaceuticals (Wuhan) Co. Ltd. via HKEXnews

Filed with HKEX · Stock code 3378 · · 3 pages · English

Summary by 6ix AI

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. has announced a strategic cooperation with Shenzhen XtalPi Technology Co., Ltd. to explore the application of AI in drug research and development. The cooperation aims to enhance R&D efficiency and success rates while optimizing biologics screening and molecule optimization processes. The specific terms of the cooperation will be determined through subsequent agreements based on actual needs. This announcement is made voluntarily by the company's board of directors.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. on 6ix

Earlier from Hanx Biopharmaceuticals (Wuhan)

Later from Hanx Biopharmaceuticals (Wuhan)

All Hanx Biopharmaceuticals (Wuhan) news releases